SUDEEP PHARMA LIMITED vs TORRENT PHARMACEUTICALS L

A side-by-side comparison of SUDEEP PHARMA LIMITED (SUDEEPPHRM) and TORRENT PHARMACEUTICALS L (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

SUDEEP PHARMA LIMITED vs TORRENT PHARMACEUTICALS L are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.

  • Valuation13
  • Profitability31
  • Growth20
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

TORNTPHARM takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

80.36
P/E ratio
77.50
12.37
P/B ratio
18.67
0.13%
Dividend yield
0.76%
₹15.31
EPS
₹63.92

Profitability

SUDEEPPHRM takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

25.20%
Return on equity
27.40%
28.00%
Return on capital
15.00%
35.00%
EBITDA margin
33.00%
27.10%
Net margin
15.29%

Growth

SUDEEPPHRM takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.38%
Revenue CAGR (3Y)
13.27%
41.05%
Profit CAGR (3Y)
19.75%

Size & financial health

TORNTPHARM takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹13,964 Cr
Market cap
₹1.68L Cr
₹642 Cr
Revenue
₹13,980 Cr
₹174 Cr
Net profit
₹2,138 Cr
0.16
Debt / equity
1.69
SUDEEP PHARMA LIMITED
  • + ["Company has delivered good profit growth of 39.0% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 31.8%"]
  • ["Stock is trading at 14.7 times its book value"]
TORRENT PHARMACEUTICALS L
  • + ["Company is expected to give good quarter", "Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
  • ["Stock is trading at 20.4 times its book value", "Promoter holding has decreased over last quarter: -7.53%", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
SUDEEP PHARMA LIMITED full analysis TORRENT PHARMACEUTICALS L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

SUDEEPPHRM vs TORNTPHARM: Share Price, Valuation & Which to Buy | DocStoX